Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Deferred Taxes (2016 - 2018)

Historic Deferred Taxes for Cryo Cell International (CCEL) over the last 5 years, with Q4 2018 value amounting to -$738772.0.

  • Cryo Cell International's Deferred Taxes rose 1291.33% to -$738772.0 in Q4 2018 from the same period last year, while for Nov 2018 it was $2.4 million, marking a year-over-year increase of 20234.0%. This contributed to the annual value of -$309274.0 for FY2024, which is 9541.84% up from last year.
  • According to the latest figures from Q4 2018, Cryo Cell International's Deferred Taxes is -$738772.0, which was up 1291.33% from $93826.0 recorded in Q3 2018.
  • Cryo Cell International's Deferred Taxes' 5-year high stood at $3.0 million during Q1 2018, with a 5-year trough of -$1.1 million in Q4 2016.
  • Over the past 4 years, Cryo Cell International's median Deferred Taxes value was -$218287.0 (recorded in 2015), while the average stood at $6797.9.
  • In the last 5 years, Cryo Cell International's Deferred Taxes plummeted by 15923.97% in 2016 and then soared by 129684.38% in 2018.
  • Cryo Cell International's Deferred Taxes (Quarter) stood at -$412679.0 in 2015, then crashed by 159.24% to -$1.1 million in 2016, then rose by 20.71% to -$848318.0 in 2017, then increased by 12.91% to -$738772.0 in 2018.
  • Its Deferred Taxes stands at -$738772.0 for Q4 2018, versus $93826.0 for Q3 2018 and -$23895.0 for Q2 2018.